On-dose identification for tablets and capsules – dosage design and equipment innovation to mitigate risks in patient safety and brand protection

On-dose identification for tablets and capsules – dosage design and equipment innovation to mitigate risks in patient safety and brand protection

04/17/2018, 2:30 PM - 3:15 PM

Technical Conference Stage 4, Booth 1477, Exhibit Hall
Language:
English

Many business needs can be satisfied by providing unique identification on solid oral dosage forms. But there is truly only one purpose: patient safety. Managing risk in the increasingly complex supply chain for solid dosage products should start directly with the tablets and capsules, and their unique on-dose identification. This presentation will describe how dosage design and on-dose identifiers can help mitigate risks in patient safety and brand protection. Beyond FDA requirements, there are business drivers and product enhancements that can help better serve the industry and patient community and these will be described. Looking forward, the author will present some new developments in the industry, such as equipment innovations that can possibly allow drug makers to "serialize the dose." Each form of equipment has its own range of capabilities and limitations and these will be compared to help audience members understand which technology can best suit their needs.

Contributors

  • Edward Novit

    Speaker

    Business Development Manager

    Freund-Vector Corporation

    Mr. Novit has been active in the solid dosage industry since 2001, mainly with compression and coating. Experience has been with pharma equipment...

Type of Session

  1. Type of Session
    Session

Learning Objectives

  1. Learning Objectives 1. Understand the minimum requirements of FDA regulations for imprinting on solid oral dosage forms (21 CFR Part 206) 2. Identify and understand the available technologies for applying visual identifiers onto solid dosage products (debossing, rubber transfer roll printing, Tampo pad printing, inkjet, laser marking) 3. Be able to describe how visual identifiers on solid oral dosage forms can help reduce risk in at least 3 of these areas: patient adherence, dispensing errors, counterfeiting, branding, product expiration, authentication

Categories

  1. Track
    Risk Management

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.